Latest News
Posting for the inaugural G. Raymond Chang Professorship in Mature Women’s Health
Posting for the inaugural G. Raymond Chang Professorship in Mature Women’s Health
CMS/Pfizer Research Award is now closed
Thank you for your interest. The research award is now closed. We would like to announce that the Canadian Menopause Society/Pfizer Menopause Awards (CMS/Pfizer Menopause...
Canadian Menopause Society welcomes FDA decision to remove “Black Box” warning from menopausal hormone therapy labels
Canadian Menopause Society welcomes FDA decision to remove “Black Box” warning from menopausal hormone therapy labels
La Société canadienne de la ménopause se réjouit de la décision de la FDA de retirer l’avertissement « Black Box » de l’étiqueta
La Société canadienne de la ménopause se réjouit de la décision de la FDA de retirer l’avertissement « Black Box » de l’étiquetage du traitement hormonal de la ménopause
Education Program for Health Care Providers
Canadian Menopause Society Two Parts Education Program for Health Care Providers
Press Release
Canadian Menopause Society Hosts Landmark Scientific Meeting in Montreal with Global Leaders in Midlife Women's Health
Keynote Speaker at Montréal National Scientific Conference - Dr. Claudio Soares
Keynote speaker at Montréal national scientific conference
Keynote Speaker at Montréal National Scientific Conference - Dr. Rossella Nappi
Keynote speakers at Montréal national scientific conference
Academic Promotion for CMS President - Dr. Nese Yuksel
Congratulations to our President Dr. Nese Yuksel who has been appointed as the new Vice Dean at Faculty of Pharmacy and Pharmaceutical Sciences in the College of Health Sciences, University of Alberta....
NEW APPROVED MENOPAUSAL THERAPIES IN CANADA - Bijuva and Imvexxy
Knight Therapeutics Inc. announced the launch of Imvexxy® and Bijuva®. In Canada, Imvexxy is for the treatment of postmenopausal moderate to severe dyspareunia, a symptom of vulvar and...
